Business context and reporting period
The supplied filing is Prime Estates & Developments, Inc.’s Form 10-Q, not a filing identified as Cosmos Health Inc. It covers the quarter and nine months ended April 30, 2012; the company’s fiscal year-end is July 31. The filing describes Prime Estates as a development-stage company formed to acquire and operate real estate assets. It reports no completed property acquisitions or revenue-generating closings.
Financial performance and position
- Revenue: None reported for the three or nine months ended April 30, 2012.
- Net loss: $54,564 for the three months and $270,863 for the nine months ended April 30, 2012, compared with $87,349 and $107,834, respectively, in the comparable 2011 periods.
- Expenses: Nine-month general and administrative expense was $267,404, up from $107,199. Three-month expense was $52,825, down from $87,190. Nine-month related-party interest expense was $3,459 versus $635; three-month expense was $1,739 versus $159.
- Margins: Not meaningful because the company reported no revenue.
- Cash flow: Nine-month operating cash use was $54,126, compared with $41,078 in 2011. Financing provided $38,923, including $14,823 of related-party borrowing and $24,100 from common-stock sales. Cash declined from $15,238 to $35.
- Liquidity and liabilities: At April 30, 2012, cash was $35, total assets $1,506, and current liabilities $161,672, including $145,000 of related-party accrued expenses and a $14,823 related-party note. The resulting working-capital deficit was $160,166. The filing reports no cash paid for interest or income taxes.
- Equity: Shareholders’ deficit was $160,166, versus $4,762 at July 31, 2011. Shares outstanding were 24,709,282 at April 30, 2012, up from 24,514,282.
Material changes, outlook and risks
Nine-month general and administrative costs rose mainly because of accrued costs under the GreenEra agreement, officer and director salaries, and $87,900 of noncash stock compensation. The nine-month net loss increased from 2011; the lower three-month loss reflected the absence of a prior-year noncash compensation charge.
Management estimated that at least $120,000 would be needed for the next 12 months, in addition to funds for maintaining public-company status, and estimated a monthly burn rate of about $10,000. It planned to seek additional financing and pursue property acquisitions, but disclosed no specific funding agreement; management loans were anticipated but not committed. The company stated that without additional funds by the end of 2012 it might be unable to continue operations. Its plans to raise as much as $10 million and acquire properties were targets, not assured outcomes.
The GreenEra arrangement concerns exploitation rights for approximately 150,000 acres in Brazil and potential carbon-credit development. It calls for $5,000 monthly payments for approximately 34 years, with a right to cancel, and financing of project costs up to $1.2 million. The company had accrued $65,000 under the contract and made no cash payments through April 30, 2012. Carbon-credit certification and sales were uncertain, and the filing notes that two directors were shareholders of GreenEra. Management and the filing state that losses, the working-capital deficit, and the need for capital raise substantial doubt about the company’s ability to continue as a going concern. Disclosure controls and procedures were deemed ineffective. No legal proceedings were reported.
Important facts for investors to verify
- Confirm the issuer and reporting period: the supplied text identifies Prime Estates, not Cosmos Health, and reports a period ended April 30, 2012.
- Assess the company’s ability to fund operations given $35 in cash, the $160,166 working-capital deficit, and the absence of committed financing.
- Review the related-party balances, management funding expectations, and directors’ relationship to GreenEra.
- Verify the terms, accrued obligations, cancellation rights, and certification and commercialization status of the GreenEra project.
- Consider the ineffective disclosure controls and going-concern uncertainty; the filing provides no revenue or completed acquisition track record.